For research use only. Not for therapeutic Use.
Sodium Salicylate(Cat No.: A001025) is the sodium salt of salicylic acid. As a nonsteroidal anti-inflammatory drug (NSAID), sodium salicylate irreversibly acetylates cyclooxygenases I and II, thereby inhibiting prostaglandin synthesis and associated inflammation and pain. This agent may also activate mitogen-activated protein kinase (p38MAPK), thereby inducing apoptosis in cancer cells.
Catalog Number | A001025 |
CAS Number | 54-21-7 |
Synonyms | Sodium 2-hydroxybenzoate |
Molecular Formula | C7H5NaO3 |
Purity | ≥95% |
Target | NF-κB |
Solubility | >7.1mg/mL in DMSO |
Storage | RT |
Overview of Clinical Research | Originator: Catabasis Pharmaceuticals<br /> |
IUPAC Name | sodium;2-hydroxybenzoate |
InChI | InChI=1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1 |
InChIKey | ABBQHOQBGMUPJH-UHFFFAOYSA-M |
SMILES | C1=CC=C(C(=C1)C(=O)[O-])O.[Na+] |
Reference | [1]: Girard M, Hu D, Pradervand N, Neuenschwander S, Bee G. Chestnut extract but not sodium salicylate decreases the severity of diarrhea and enterotoxigenic Escherichia coli F4 shedding in artificially infected piglets. PLoS One. 2020 Feb 27;15(2):e0214267. doi: 10.1371/journal.pone.0214267. PMID: 32106264; PMCID: PMC7046202.<br /> |